For pharmacokinetic studies in healthy rats, TRO40303 was administered formulated in IL30 at the doses used in the myocardial infarction model and results analyzed in comparison with pharmacokinetic data obtained with TRO40303 formulated in HPBCD at 2.5 mg/kg. Here, IL27 is linked to myocardial infarction.